sulofenur has been researched along with Anemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnay, M; Droz, JP; Kattan, J; Mahjoubi, M; Schmitt, H | 1 |
| Brown, TD; Burris, HA; Cagnola, J; Craig, JB; Grindey, GB; Hamilton, JM; Havlin, K; Kuhn, JG; O'Rourke, TJ; Satterlee, WG | 1 |
| Alberts, DS; Grindey, GB; Hamilton, M; Matzner, M; McCloskey, TM; Peng, YM; Plezia, PM; Roe, DJ; Seitz, D; Taylor, CW | 1 |
3 trial(s) available for sulofenur and Anemia
| Article | Year |
|---|---|
Phase II trial of LY 186641 in advanced renal cancer.
Topics: Administration, Oral; Adult; Aged; Anemia; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Sulfonylurea Compounds | 1993 |
Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule.
Topics: Administration, Oral; Anemia; Antineoplastic Agents; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Hemolysis; Humans; Male; Methemoglobinemia; Middle Aged; Neoplasms; Sulfonylurea Compounds | 1994 |
Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Carcinoma; Drug Administration Schedule; Female; Humans; Methemoglobinemia; Middle Aged; Ovarian Neoplasms; Sulfonylurea Compounds | 1992 |